首页> 外国专利> AROMATIC DERIVATIVES OF SULFANILAMIDES CARBONIC ANHYDRASE II (CA II) INHIBITORS, METHODS FOR PRODUCTION AND USE THEREOF

AROMATIC DERIVATIVES OF SULFANILAMIDES CARBONIC ANHYDRASE II (CA II) INHIBITORS, METHODS FOR PRODUCTION AND USE THEREOF

机译:磺酰胺类碳酸酐酶II(CA II)抑制剂的芳香族衍生物,生产方法及其用途

摘要

FIELD: chemistry.;SUBSTANCE: present invention relates to novel aromatic sulphonamide derivatives, general formula 1 and pharmaceutically acceptable salts thereof, which are selective inhibitors of carbonic anhydrase II (CA II). Substituted sulphonamides correspond to general formula 1; ,;where A is phenyl or thiophene; R1 is C1-C5alkyl, C-3C6cycloalkyl, -C(O)R3; provided that R1 is not methyl, when A is phenyl, R2 represents hydrogen; R3 is a 5-6 member heterocyclyl with one or two heteroatoms, selected from nitrogen or oxygen atoms; R2 is C1-C3alkyl, C1-C3alkoxy. Invention also relates to a method of producing compounds of general formula 1. Method involves two stages: a) sulphochlorination of corresponding oxazole derivative of general formula 5 (a-o) or 6 (a-j) with a mixture chlorosulphonic acid and thionyl chloride to produce intermediate sulphochlorides of formula 7 (a-o) or 8 (a-j), respectively, and b) with subsequent conversion of obtained sulphochlorides into primary sulphamides of formula 9 (b-o) or 10 (a-j) by reacting with ammonia according to following scheme; ,;where; ,;where R1 is C1-C5alkyl, C3-C6cycloalkyl; NR'Rʺ is a morpholine or pyrrolidine.;EFFECT: compounds can be used for treating glaucoma, in particular, open-angle glaucoma, and other diseases caused by high intraocular pressure, age-related macular degeneration, diabetic macular edema, diabetic retinopathy, hypertensive retinopathy and retinal vasculopathy mediated by activity of carbonic anhydrase II.;11 cl, 2 dwg, 2 tbl, 57 ex
机译:技术领域本发明涉及新型的芳香族磺​​酰胺衍生物,通式1及其药学上可接受的盐,其为碳酸酐酶II(CA II)的选择性抑制剂。取代的磺酰胺对应于通式1; ,其中A是苯基或噻吩; R 1 是C 1 -C 5 烷基,C -3 C 6 环烷基-C(O)R 3 ;假设R 1 不是甲基,当A是苯基时,R 2 代表氢; R 3 是具有一个或两个选自氮或氧原子的杂原子的5-6元杂环基; R 2 是C 1 -C 3 烷基,C 1 -C 3 烷氧基。本发明还涉及一种制备通式1的化合物的方法。该方法包括两个阶段:a)用氯磺酸和亚硫酰氯的混合物对相应的通式5(ao)或6(aj)的恶唑衍生物进行磺氯化,以生产中间体磺酰氯。分别由式(7)(ao)或式(8)和(b)分别制得,然后将所得的硫代氯化物通过与氨反应按照以下方案转化为式9(bo)或10(aj)的伯磺酰胺; ,;其中; ,;其中R 1 是C 1 < / Sub> -C 5 烷基,C 3 -C 6 环烷基; NR'R 3是吗啉或吡咯烷。功效:该化合物可用于治疗青光眼,尤其是开角型青光眼,以及由高眼压,年龄相关性黄斑变性,糖尿病性黄斑水肿,糖尿病性视网膜病,碳酸酐酶II的活性介导的高血压性视网膜病变和视网膜血管病变; 11 cl,2 dwg,2 tbl,57 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号